Abstract
Six years after the first Society guidelines were published, cryptococcal meningitis (CM) remains an important cause of morbidity and mortality among HIV-infected adults in South Africa. Several important developments have spurred the publication of updated guidelines to manage this common fungal opportunistic infection. Recommendations described here include: (1) screening and pre-emptive treatment; (2) laboratory diagnosis and monitoring; (3) management of a first episode of CM; (4) amphotericin B deoxycholate toxicity prevention, monitoring and management; (5) timing of antiretroviral therapy among patients with CM; (6) management of raised intracranial pressure; (7) management of relapse episodes of CM.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 76-86 |
| Number of pages | 11 |
| Journal | Southern African Journal of HIV Medicine |
| Volume | 14 |
| Issue number | 2 |
| DOIs | |
| State | Published - Jun 2013 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
-
SDG 5 Gender Equality
Fingerprint
Dive into the research topics of 'Guideline for the prevention, diagnosis and management of cryptococcal meningitis among HIV-infected persons: 2013 update'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS